
CASPOFUNGIN AND NNRTIS
Population data suggests that efavirenz and nevirapine may reduce caspofungin levels. This is in line with the known enzyme-inducing properties of these NNRTIs.
The manufacturers say that consideration should be given to increasing the dose of caspofungin from 50 to 70 mg daily.
The manufacturers say that consideration should be given to increasing the dose of caspofungin from 50 to 70 mg daily.